Skip to main content
Signal8
Cohen Gal Avraham profile photo

Gal Avraham Cohen

CIK: 0002015226

Transaction Breakdown

Open Market Buys (P)0

High conviction signal

Open Market Sales (S)0

Position reduction

Option Exercises (M)0

Derivative conversions

Awards (A)0

Compensation grants

Other (G, F, J, C, D, …)0

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioLineRx Ltd. logo
BLRX

BioLineRx Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (0 total)

1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.

0-0 of 0

Gal Avraham Cohen files insider reports with the SEC as Director of BioLineRx Ltd. (BLRX).

About Cohen Gal Avraham

Cohen Gal Avraham (SEC CIK 0002015226) files insider reports with the SEC as Director of BioLineRx Ltd. (BLRX).

Signal8 holds 1 ownership filing by Cohen Gal Avraham, a Form 3, filed on Mar 30, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.

The business address on Cohen Gal Avraham's filings is in MODII'N.

Other insiders filing for BioLineRx Ltd. (BLRX)

How to read Form 4 transaction codes